These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6642598)

  • 21. [Prevention of pregnancy by using intrauterine contraceptive devices].
    Toĭvonen Iu
    Akush Ginekol (Mosk); 1990 Dec; (12):53-4. PubMed ID: 2090000
    [No Abstract]   [Full Text] [Related]  

  • 22. Intrauterine devices.
    Bilian X
    Best Pract Res Clin Obstet Gynaecol; 2002 Apr; 16(2):155-68. PubMed ID: 12041959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Uterine perforation by a spiral IUD].
    Onsrud M
    Tidsskr Nor Laegeforen; 1979 Nov; 99(33):1711-3. PubMed ID: 575237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper intrauterine device use by nulliparous women: review of side effects.
    Hubacher D
    Contraception; 2007 Jun; 75(6 Suppl):S8-11. PubMed ID: 17531622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Actinomycosis and intrauterine spiral. 4 case reports].
    Puchner T; Egarter C; Reisenberger K; Kiss H
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):311-3. PubMed ID: 8050694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytologic monitoring of women using copper-containing intrauterine devices: five-year follow-up study.
    Luthra UK; Mitra AB; Prabhakar AK; Agarwal SS; Bhatnagar P
    Acta Cytol; 1982; 26(5):619-22. PubMed ID: 6959449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hysterography and the IUD.
    Reiertsen O; Eyjolfsson O
    Contracept Deliv Syst; 1980 Oct; 1(4):389-98. PubMed ID: 12262142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immediate postabortion intrauterine contraception in nulliparous adolescents.
    Goldman JA; Dekel A; Reichman J
    Isr J Med Sci; 1979 Jun; 15(6):522-5. PubMed ID: 457386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care provider attitudes and practices related to intrauterine devices for nulliparous women.
    Tyler CP; Whiteman MK; Zapata LB; Curtis KM; Hillis SD; Marchbanks PA
    Obstet Gynecol; 2012 Apr; 119(4):762-71. PubMed ID: 22433340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial.
    Wu S; Godfrey EM; Wojdyla D; Dong J; Cong J; Wang C; von Hertzen H
    BJOG; 2010 Sep; 117(10):1205-10. PubMed ID: 20618314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term use of Cu T 200.
    Prema K; Gayathri TL; Philips FS
    J Obstet Gynaecol India; 1978 Dec; 28(6):949-53. PubMed ID: 751824
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease.
    Suri V; Aggarwal N; Kaur R; Chaudhary N; Ray P; Grover A
    Contraception; 2008 Oct; 78(4):315-8. PubMed ID: 18847580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting, more effective copper T IUDs: a summary of U.S. experience, 1970-75.
    Sivin I; Stern J
    Stud Fam Plann; 1979 Oct; 10(10):263-81. PubMed ID: 516121
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical studies of the use of Cu 7 and Cu T intrauterine devices].
    Monteforte C; Disparti P
    Ann Ostet Ginecol Med Perinat; 1979; 100(1):55-61. PubMed ID: 426440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copper 7 devices devoid of copper: implications for duration of useful life.
    Goh TH
    Med J Aust; 1979 May; 1(10):468-9. PubMed ID: 470693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cervical perforation due to a copper-T device placed following abortion (author's transl)].
    Wagner K; Quakernack K; Schmidt EH
    Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):184-6. PubMed ID: 1254162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atomic absorption spectrophotometry study of copper ion release by copper-bearing intrauterine devices].
    Berthou J; Chrétien FC; Driguez PA
    Contracept Fertil Sex; 1998 Nov; 26(11):781-9. PubMed ID: 9864885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.